Craft

Sagittarius Life Science

Stock Price

NT$37

2024-10-29

Market Capitalization

NT$1.2 B

2024-10-29

Revenue

NT$467.8 M

FY, 2024

Sagittarius Life Science Summary

Company Summary

Overview
Sagittarius Life Science (佰研生化科技股份有限公司) is a biotechnology company that researches and develops botanical drug products. It offers herbal medicines and nutritional supplements for the treatment of bone fractures, osteoporosis, wound healing, and skin care diseases.
Type
Public
Status
Active
Founded
1998
Website
https://www.naturalbiokey.com
Cybersecurity rating
Sectors

Table of Contents

Sagittarius Life Science Financials

Summary Financials

Revenue (Q3, 2025)
NT$92.9M
Gross profit (Q3, 2025)
NT$16.0M
Net income (Q3, 2025)
(NT$7.0M)
Cash (Q3, 2025)
NT$163.6M
EBIT (Q3, 2025)
(NT$13.2M)
Enterprise value
$1.0B

Footer menu